The global medicalmembrane market was valued at US$ 2900.45 Mn in 2017 and isanticipated to expand at a CAGR of 9.5% from 2018 to 2026, according to a newreport titled ‘Medical Membrane Market: Global Industry Analysis,Size, Share, Growth, Trends, and Forecast, 2018–2026,’ published byTransparency Market Research (TMR). The global medical membrane market isdriven by growth of pharmaceutical and health care industries across the world.North America accounts for a major share of the global market, due to growinghealth care and pharmaceutical sectors in the region.
Growthof pharmaceutical and health care industries
Growth ofpharmaceutical and health care industries, especially in developing economies,drives the demand for medical membranes. In the U.S., health care spendingaccounts for 17% of the country’s gross domestic product (GDP). Health carecosts are increasing at a rate twice the country’s economic growth rate. Incountries of Europe, where single-payer systems is a norm, health care costsare surpassing the national and regional growth rate. According to theOrganization for Economic Co-operation & Development (OECD), health carespending constitutes an average of 9.5% of GDP in case of 34 OECD countries inNorth and South America, Europe, and Asia Pacific. The average annual growthrate of health care costs for member countries of the OECD is 4.9% (whichexceeds the U.S. rate). In China, where most people in the country are insured,health care spending is rising at a rate of 16%. As per the worldwidephenomenon, the capital available to pay for health care is either decreasingor stagnant, while health care costs are rising. The pharmaceutical sector isexpected to remain stagnant or witness slowdown over the next 10 years.
Request Sample
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=48726
Long in-process validation torestraint the medical membrane market
Medicalmembrane biomaterials can be defined as substances in therapeutic or diagnosticsystems that come in contact with biological fluids. Biomaterials are requiredto have blood compatibility, size, shape, and porosity, depending onfunctionality of the final device. Biomaterials need to prevent infection andimmune responses, blood clotting, and other biological responses that couldaffect properties of the biological fluid and the patient’s organ. This callsfor long in-process validation to know the host response and the response ofmaterials such as PVDF, PTFE, and PP to a biomaterial.
More Trending Reports
Polyvinylidene fluoride segment todominate the global medical membrane market
Based onmaterial, the global medical membrane market has been segmented intopolysulfone & polyether sulfone, polyvinylidene fluoride (hydrophobicpolyvinylidene fluoride, hydrophilic polyvinylidene fluoride),polytetrafluoroethylene, polypropylene, modified acrylics, and others.Polyvinylidene fluoride (PVDF) is the most commonly used material of medical membranes,which is applied for separation of mediums in pharmaceutical, life sciences,biotechnology, and health care sectors. PVDF membranes possess properties suchas high hydrophobicity, thermal stability, chemical resistance, and excellentmechanical strength. Key applications of PVDF membranes include sterilizingfiltration, filtration of protein-containing solutions, mycoplasma reduction,filtration of gases, and venting.
Request Covid19 analysis on thismarket
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=48726
Ultrafiltration segment dominatesthe global medical membrane market
In terms offiltration type, the global medical membrane market has been segmented intoultrafiltration, microfiltration, nanofiltration, and others. Theultrafiltration segment is projected to dominate the medical membrane marketduring the forecast period, due to increase in the use of the ultrafiltrationprocess technology in pharmaceutical filtration. Nanofiltration is expected tobe the rapidly expanding segment of the market from 2018 to 2026. This isbecause nanofiltration is carried out at reduced operating pressures withincreased flow rates. Research & development of solvent-stable membraneshas expanded the applicability of nanofiltration in new areas such aspharmaceuticals and fine chemicals, thereby driving the nanofiltration segment.Nanofiltration is a relatively new membrane filtration process technology usedfor softening and removal of divalent ions, organics, color, bacteria, andviruses. It is also employed in food and pharmaceutical applications.
Pharmaceutical filtration segmentdominates the global medical membrane market
In terms ofapplication, the global medical membrane market can be segmented intopharmaceutical filtration, hemodialysis, drug delivery, intravenous (IV)infusion & sterile filtration, and others. The pharmaceutical filtration segmentis projected to dominate the medical membrane market during the forecastperiod. High rate of incidence of renal diseases, advancements in the medicaltechnology, growth of pharmaceutical and health care industries, and increasingdemand for high-purity materials and medicines are driving the pharmaceuticalfiltration segment.
Buy Now
https://www.transparencymarketresearch.com/checkout.php?rep_id=48726<ype=S
North America dominates the globalmedical membrane market
Based onregion, the global medical membrane market can be classified into NorthAmerica, Europe, Asia Pacific, Middle East & Africa, and Latin America.North America dominates the global market, due to growth of pharmaceutical andhealth care industries in the region. In the U.S., health care spendingaccounts for 17% of the country’s gross domestic product (GDP). Health carecosts are increasing at a rate twice the country’s economic growth rate. Europeconstitutes the second-largest share of the global medical membrane market. Themarket in the region is driven by increasing elderly population, growing poolof patients with end-stage renal disease (ESRD), increasing availability ofimproved diagnostic facilities, and rising incidence of chronic diseases suchas diabetes and hypertension in Europe. The market in Asia Pacific isanticipated to witness rapid growth during the forecast period. Significantgrowth of the medical membrane market in countries such as India and China isexpected to boost the market in Asia Pacific between 2018 and 2026. Risingprevalence of diabetes, growing demographics, and expanding medical careindustry are expected to drive the medical membrane market in these countriesfrom 2018 to 2026. In China, where most people in the country are insured,health care spending is increasing at a rate of 16% per year.
High degree of competition amongmarket players
The globalmedical membrane market witnesses high degree of competition among marketplayers. The market is dominated by large players which are technologicallyadvanced. The medical membrane market is capital intensive and technologyintensive. Some of the key players operating in the market are PallCorporation, Merck KGaA, 3M, General Electric Company, Asahi Kasei Corporation,Sartorius, Cobetter Filtration Equipment Co., Ltd, and W. L. Gore &Associates, Inc.
About Us
Transparency Market Research (TMR) is a global marketintelligence company providing business information reports and services. Thecompany’s exclusive blend of quantitative forecasting and trend analysisprovides forward-looking insight for thousands of decision makers. TMR’s experiencedteam of analysts, researchers, and consultants use proprietary data sources andvarious tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by ateam of research experts so that it always reflects the latest trends andinformation. With extensive research and analysis capabilities, TransparencyMarket Research employs rigorous primary and secondary research techniques todevelop distinctive data sets and research material for business reports.
Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
